vs
Progyny, Inc.（PGNY）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是Progyny, Inc.的1.4倍（$461.6M vs $318.4M），RBC Bearings INC净利率更高（14.6% vs 3.9%，领先10.7%），RBC Bearings INC同比增速更快（17.0% vs 6.7%），RBC Bearings INC自由现金流更多（$99.1M vs $48.6M），过去两年Progyny, Inc.的营收复合增速更高（7.0% vs 5.6%）
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
PGNY vs RBC — 直观对比
营收规模更大
RBC
是对方的1.4倍
$318.4M
营收增速更快
RBC
高出10.3%
6.7%
净利率更高
RBC
高出10.7%
3.9%
自由现金流更多
RBC
多$50.5M
$48.6M
两年增速更快
PGNY
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $318.4M | $461.6M |
| 净利润 | $12.5M | $67.4M |
| 毛利率 | 24.1% | 44.3% |
| 营业利润率 | 4.8% | 22.3% |
| 净利率 | 3.9% | 14.6% |
| 营收同比 | 6.7% | 17.0% |
| 净利润同比 | 18.5% | 16.4% |
| 每股收益（稀释后） | $0.14 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PGNYRBC
| Q4 25 | $318.4M | $461.6M | ||
| Q3 25 | $313.3M | $455.3M | ||
| Q2 25 | $332.9M | $436.0M | ||
| Q1 25 | $324.0M | $437.7M | ||
| Q4 24 | $298.4M | $394.4M | ||
| Q3 24 | $286.6M | $397.9M | ||
| Q2 24 | $304.1M | $406.3M | ||
| Q1 24 | $278.1M | $413.7M |
净利润PGNYRBC
| Q4 25 | $12.5M | $67.4M | ||
| Q3 25 | $13.9M | $60.0M | ||
| Q2 25 | $17.1M | $68.5M | ||
| Q1 25 | $15.1M | $72.7M | ||
| Q4 24 | $10.5M | $57.9M | ||
| Q3 24 | $10.4M | $54.2M | ||
| Q2 24 | $16.5M | $61.4M | ||
| Q1 24 | $16.9M | — |
毛利率PGNYRBC
| Q4 25 | 24.1% | 44.3% | ||
| Q3 25 | 23.2% | 44.1% | ||
| Q2 25 | 23.7% | 44.8% | ||
| Q1 25 | 23.4% | 44.2% | ||
| Q4 24 | 21.3% | 44.3% | ||
| Q3 24 | 20.7% | 43.7% | ||
| Q2 24 | 22.5% | 45.3% | ||
| Q1 24 | 22.4% | 43.1% |
营业利润率PGNYRBC
| Q4 25 | 4.8% | 22.3% | ||
| Q3 25 | 6.9% | 21.5% | ||
| Q2 25 | 7.3% | 23.2% | ||
| Q1 25 | 7.5% | 23.0% | ||
| Q4 24 | 5.3% | 21.7% | ||
| Q3 24 | 4.3% | 21.6% | ||
| Q2 24 | 6.8% | 24.0% | ||
| Q1 24 | 6.7% | 22.8% |
净利率PGNYRBC
| Q4 25 | 3.9% | 14.6% | ||
| Q3 25 | 4.4% | 13.2% | ||
| Q2 25 | 5.1% | 15.7% | ||
| Q1 25 | 4.6% | 16.6% | ||
| Q4 24 | 3.5% | 14.7% | ||
| Q3 24 | 3.6% | 13.6% | ||
| Q2 24 | 5.4% | 15.1% | ||
| Q1 24 | 6.1% | — |
每股收益（稀释后）PGNYRBC
| Q4 25 | $0.14 | $2.13 | ||
| Q3 25 | $0.15 | $1.90 | ||
| Q2 25 | $0.19 | $2.17 | ||
| Q1 25 | $0.17 | $2.33 | ||
| Q4 24 | $0.12 | $1.82 | ||
| Q3 24 | $0.11 | $1.65 | ||
| Q2 24 | $0.17 | $1.90 | ||
| Q1 24 | $0.17 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.2M | $107.6M |
| 总债务越低越好 | — | $990.2M |
| 股东权益账面价值 | $516.0M | $3.3B |
| 总资产 | $742.4M | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资PGNYRBC
| Q4 25 | $112.2M | $107.6M | ||
| Q3 25 | $134.0M | $91.2M | ||
| Q2 25 | $132.5M | $132.9M | ||
| Q1 25 | $109.2M | $36.8M | ||
| Q4 24 | $162.3M | — | ||
| Q3 24 | $91.5M | — | ||
| Q2 24 | $95.0M | $76.8M | ||
| Q1 24 | $115.0M | $63.5M |
总债务PGNYRBC
| Q4 25 | — | $990.2M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $915.6M | ||
| Q1 25 | — | $920.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.2B |
股东权益PGNYRBC
| Q4 25 | $516.0M | $3.3B | ||
| Q3 25 | $560.0M | $3.2B | ||
| Q2 25 | $515.0M | $3.1B | ||
| Q1 25 | $467.2M | $3.0B | ||
| Q4 24 | $422.1M | $2.9B | ||
| Q3 24 | $434.9M | $2.9B | ||
| Q2 24 | $456.2M | $2.8B | ||
| Q1 24 | $571.6M | $2.8B |
总资产PGNYRBC
| Q4 25 | $742.4M | $5.1B | ||
| Q3 25 | $795.2M | $5.1B | ||
| Q2 25 | $761.0M | $4.8B | ||
| Q1 25 | $730.3M | $4.7B | ||
| Q4 24 | $607.1M | $4.7B | ||
| Q3 24 | $660.0M | $4.7B | ||
| Q2 24 | $698.6M | $4.7B | ||
| Q1 24 | $794.3M | $4.7B |
负债/权益比PGNYRBC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.2M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $48.6M | $99.1M |
| 自由现金流率自由现金流/营收 | 15.3% | 21.5% |
| 资本支出强度资本支出/营收 | 1.8% | 5.0% |
| 现金转化率经营现金流/净利润 | 4.34× | 1.81× |
| 过去12个月自由现金流最近4个季度 | $191.8M | — |
8季度趋势，按日历期对齐
经营现金流PGNYRBC
| Q4 25 | $54.2M | $122.1M | ||
| Q3 25 | $50.7M | $88.4M | ||
| Q2 25 | $55.5M | $120.0M | ||
| Q1 25 | $49.8M | — | ||
| Q4 24 | $52.2M | $84.0M | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $56.7M | $97.4M | ||
| Q1 24 | $25.7M | — |
自由现金流PGNYRBC
| Q4 25 | $48.6M | $99.1M | ||
| Q3 25 | $46.0M | $71.7M | ||
| Q2 25 | $50.2M | $104.3M | ||
| Q1 25 | $47.0M | — | ||
| Q4 24 | $50.3M | $73.6M | ||
| Q3 24 | $42.7M | — | ||
| Q2 24 | $55.8M | $88.4M | ||
| Q1 24 | $24.9M | — |
自由现金流率PGNYRBC
| Q4 25 | 15.3% | 21.5% | ||
| Q3 25 | 14.7% | 15.7% | ||
| Q2 25 | 15.1% | 23.9% | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | 16.8% | 18.7% | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 18.4% | 21.8% | ||
| Q1 24 | 8.9% | — |
资本支出强度PGNYRBC
| Q4 25 | 1.8% | 5.0% | ||
| Q3 25 | 1.5% | 3.7% | ||
| Q2 25 | 1.6% | 3.6% | ||
| Q1 25 | 0.9% | 3.2% | ||
| Q4 24 | 0.6% | 2.6% | ||
| Q3 24 | 0.6% | 4.1% | ||
| Q2 24 | 0.3% | 2.2% | ||
| Q1 24 | 0.3% | — |
现金转化率PGNYRBC
| Q4 25 | 4.34× | 1.81× | ||
| Q3 25 | 3.65× | 1.47× | ||
| Q2 25 | 3.24× | 1.75× | ||
| Q1 25 | 3.31× | — | ||
| Q4 24 | 4.95× | 1.45× | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 3.44× | 1.59× | ||
| Q1 24 | 1.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
